Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION (CVS)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

CVS Health Closes Down 7.26%, Largest Percent Decrease Since Nov 2016 -- Data Talk

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2018 | 10:50pm CEST

CVS Health closed at $73.19, down $5.73 or 7.26%

-- Lowest close since Aug. 15, 2018, when it closed at $71.64

-- Largest percent decrease since Nov. 8, 2016, when it fell 11.82%

-- On Wednesday, Justice Department antitrust enforcers cleared CVS Health's acquisition of Aetna after the companies took steps to ease regulators' concerns, moving the nearly $70 billion deal a major step closer to completion

-- On Wednesday, CVS Health said Eva Boratto will become chief financial officer following the closing of its acquisition of Aetna Inc.

-- Worst three-day stretch since the three days ending May 3, 2018, when it fell 10.83%

-- Down 7.02% month-to-date

-- Down 35.49% from its all-time closing high of $113.45 on July 29, 2015

-- Down 0.80% from 52 weeks ago (Oct. 12, 2017), when it closed at $73.78

-- Down 12.48% from its 52 week closing high of $83.63 on Jan. 29, 2018

-- Traded as low as $72.60; lowest intraday level since Aug. 16, 2018, when it hit $72.00

-- Down 8.01% at today's intraday low; largest intraday percent decrease since June 28, 2018, when it fell as much as 10.01%

-- Today's preliminary volume is 17.0 million shares; highest since Aug. 8, 2018, when 18.5 million shares were traded

-- Second-worst performer in the S&P 500 today

Source: Dow Jones Market Data, FactSet

Stocks mentioned in the article
ChangeLast1st jan.
AETNA 0.78% 200.49 Delayed Quote.10.28%
CVS HEALTH CORPORATION 0.90% 73.72 Delayed Quote.2.87%
DJ INDUSTRIAL 2.17% 25798.42 Delayed Quote.2.15%
NASDAQ 100 2.94% 7276.4263 Delayed Quote.11.89%
NASDAQ COMP. 2.89% 7645.4895 Delayed Quote.8.60%
S&P 500 2.15% 2809.92 Real-time Quote.3.50%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
10/16CVS HEALTH : to Embark on Pilot Program to Combat Diabetes in Medically Underser..
PR
10/16CVS PHARMACY : Completes Rollout of Time Delay Safes in All of Its Maryland Phar..
PR
10/16CVS PHARMACY : Completes Rollout of Time Delay Safes in All Washington, DC Pharm..
PR
10/16CVS HEALTH : Appoints New CFO, Directors Following Aetna Deal
AQ
10/15CVS HEALTH : Encourages Consumers to Safely Dispose of Prescription Drugs Ahead ..
PR
10/12CVS HEALTH : AllazoHealth Hires Former CVS Executive as Growth Accelerates
AQ
10/11CVS Health Closes Down 7.26%, Largest Percent Decrease Since Nov 2016 -- Data..
DJ
10/11CVS and Bank of America fall while Delta Air Lines climbs
AQ
10/11CVS HEALTH : MinuteClinic Launches New Virtual Care Offering in Seven Additional..
PU
10/11CVS HEALTH : MinuteClinic Opens New Walk-in Medical Clinic in Cypress, Texas
PU
More news
News from SeekingAlpha
10/16Merger Arbitrage Mondays - October 15, 2018 
10/16BRUNCH, CRAFT BEER & INVESTING : Embracing Volatility & Managing Risk 
10/15Lilly's Jardiance on CVS Caremark 2019 formulary 
10/15FDA issues new guidance aimed at more efficient drug development 
10/15Stocks Holding Up Market 
Financials ($)
Sales 2018 189 B
EBIT 2018 10 058 M
Net income 2018 1 476 M
Debt 2018 20 199 M
Yield 2018 2,82%
P/E ratio 2018 48,62
P/E ratio 2019 10,93
EV / Sales 2018 0,51x
EV / Sales 2019 0,48x
Capitalization 75 927 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 88,7 $
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Controller, Chief Financial & Accounting Officer
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORPORATION2.87%75 927
HCA HOLDINGS (HOSPITAL CORPORATION AMERICA)51.14%46 322
FRESENIUS MEDICAL CARE-3.83%30 152
LABORATORY CORPORATION OF AMERICA HOLDINGS6.28%17 309
QUEST DIAGNOSTICS1.49%13 701
DAVITA-3.17%11 504